Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Peptides|April 12, 2008
Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shockRongqian Wu, Weifeng Dong, Xiaoling Qiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2009
Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII [corrected]Michael Miksa, Rongqian Wu, Weifeng Dong, et al.
Molecular Medicine (Cambridge, Mass.)|September 26, 2009
Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsisKavin G Shah, Rongqian Wu, Asha Jacob, et al.
Neuropharmacology|October 4, 2011
Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosisCletus Cheyuo, Asha Jacob, Rongqian Wu, et al.
Biochemical and Biophysical Research Communications|May 18, 2011
Upregulation of Kupffer cell α2A-Adrenoceptors and downregulation of MKP-1 mediate hepatic injury in chronic alcohol exposureMichael A Ajakaiye, Asha Jacob, Rongqian Wu, et al.
Nature Medicine|October 8, 2013
Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsisXiaoling Qiang, Weng-Lang Yang, Rongqian Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2022
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)Zhijie Wang, Lin Wu, Baolan Li, et al.
Cancer Cell|September 10, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancerJiachen Xu, Rui Wan, Yiran Cai, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Pageof 6